Profile: AbGenomics International Inc., is a biopharmaceutical company that develops targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases. We offer several potential therapeutic antibodies for autoimmune diseases, colorectal cancer, multiple myeloma, lung cancer, lymphoma, and other solid tumors in various development stages.